Significance of Inflammatory Markers in Diabetic Patients with Stable Coronary Artery Disease
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Patients with diabetes are prone to coronary artery disease (CAD); however, the majority of diabetic patients show normal coronary arteries. We examined differences in the clinical aspects of diabetic patients with insignificant and with significant stenosis of the coronary artery. Methods: A total of 418 consecutive diabetic patients with stable angina who had undergone coronary angiography from January 2004 to March 2007 were included in this study. Patients were subdivided into control and CAD groups and then clinical characteristics and CAD-associated factors were evaluated. Results: A total of 92 (22%) patients were assigned to the control group and 326 (78%) patients were assigned to the CAD group. Using univariate regression analysis, we found that patients with CAD were significantly older (control vs. CAD; 59±21 vs. 64.7±33.7, years, p<0.001), had a longer duration of diabetes (8.2±21.8 vs. 10.2±29.8, years, p=0.027), higher titers of high sensitivity C-reactive protein (hsCRP; 0.3±6.79 vs. 0.9±12.6, mg/dL, p=0.015), and increased hemoglobin A1c (HbA1c) levels (7.1±3.8 vs. 7.5±4.8, %, p=0.007) compared to control patients. Multivariate regression analysis showed that only differences in age, hsCRP, and HbA1c were statistically significant. When patients were subdivided into groups based on hsCRP levels (208 patients in the low group [49.8%], 210 patients in the high group [50.2%]), we found that patients with higher hsCRP levels showed more frequent multivessel disease. Conclusions: In diabetic patients, age, hsCRP, and HbA1c were associated with stable CAD. Among these factors, hsCRP levels were significantly correlated with multivessel involvement in diabetic CAD. Therefore, high hsCRP levels may be a strong predictor for atherosclerotic progression of the coronary arteries in diabetic patients, suggesting that regular screening tests should be performed.
Abstract
Background/Aims: Patients with diabetes are prone to coronary artery disease (CAD); however, the majority of diabetic patients show normal coronary arteries. We examined differences in the clinical aspects of diabetic patients with insignificant and with significant stenosis of the coronary artery. Methods: A total of 418 consecutive diabetic patients with stable angina who had undergone coronary angiography from January 2004 to March 2007 were included in this study. Patients were subdivided into control and CAD groups and then clinical characteristics and CAD-associated factors were evaluated. Results: A total of 92 (22%) patients were assigned to the control group and 326 (78%) patients were assigned to the CAD group. Using univariate regression analysis, we found that patients with CAD were significantly older (control vs. CAD; 59±21 vs. 64.7±33.7, years, p<0.001), had a longer duration of diabetes (8.2±21.8 vs. 10.2±29.8, years, p=0.027), higher titers of high sensitivity C-reactive protein (hsCRP; 0.3±6.79 vs. 0.9±12.6, mg/dL, p=0.015), and increased hemoglobin A1c (HbA1c) levels (7.1±3.8 vs. 7.5±4.8, %, p=0.007) compared to control patients. Multivariate regression analysis showed that only differences in age, hsCRP, and HbA1c were statistically significant. When patients were subdivided into groups based on hsCRP levels (208 patients in the low group [49.8%], 210 patients in the high group [50.2%]), we found that patients with higher hsCRP levels showed more frequent multivessel disease. Conclusions: In diabetic patients, age, hsCRP, and HbA1c were associated with stable CAD. Among these factors, hsCRP levels were significantly correlated with multivessel involvement in diabetic CAD. Therefore, high hsCRP levels may be a strong predictor for atherosclerotic progression of the coronary arteries in diabetic patients, suggesting that regular screening tests should be performed.
참고문헌 (27)
- King H, "Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections", Diabetes Care, 21, pp.1414~1431 (1998)
- Boyle JP, "Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S", Diabetes Care, 24, pp.1936~1940 (2001)
- Wingard DL, "Heart disease and diabetes. In: National Diabetes Data Group, 2nd ed", pp.429~448 (1995), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
- Grundy SM, "Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association", Circulation, 105, pp.2231~2239 (2002)
- Butler WJ, "Mortality from coronary heart disease in the Tecumseh Study: long-term effect of diabetes mellitus, glucose tolerance and other risk factors", Am J Epidemiol, 121, pp.541~547 (1985)
- Klein R, "Hyperglycemia and microvascular and macrovascular disease in diabetes", Diabetes Care, 18, pp.258~268 (1995)
- Kleinman JC, "Mortality among diabetes in a national sample", Am J Epidemiol, 128, pp.389~401 (1988)
- Aronson D, "Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction", Ann Intern Med, 126, pp.296~306 (1997)
- Gu K, "Diabetes and decline in heart disease mortality in US adults", JAMA, 281, pp.1291~1297 (1999)
- Dandona P, "Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein", Mayo Clin Proc, 83, pp.333~342 (2008)
- Bianchi C, "Primary prevention of cardiovascular disease in people with dysglycemia", Diabetes Care, 31(2), pp.s208~s214 (2008)
- Ridker PM, "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men", N Engl J Med, 336, pp.973~979 (1997)
- Ridker PM, "C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women", N Engl J Med, 342, pp.836~843 (2000)
- Pai JK, "Inflammatory markers and the risk of coronary heart disease in men and women", N Engl J Med, 351, pp.2599~2610 (2004)
- Boekholdt SM, "C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003", Atherosclerosis, 187, pp.415~422 (2006)
- Ballantyne CM, "Lipoproteinassociated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study", Circulation, 109, pp.837~842 (2004)
- Tanne D, "C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease", Stroke, 37, pp.1720~1724 (2006)
- Blackburn R, "Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects", Arterioscler Thromb Vasc Biol, 21, pp.1962~1968 (2001)
- Kuo HK, "Sorond F. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis", Lancet Neurol, 4, pp.371~380 (2005)
- Woodward M, "Associations of inflammatory and hemostatic variables with the risk of recurrent stroke", Stroke, 36, pp.2143~2147 (2005)
- Ridker PM, "Rosuvastatin to prevent vascular events in men and women with elevated creactive protein", N Engl J Med, 359, pp.2195~2207 (2008)
- Corrado E, "Evaluation of C-reactive protein in primary and secondary prevention", J Investig Med, 55, pp.430~438 (2007)
- Jialal I, "Adams-Huet B, Devaraj S. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels", Circulation, 103, pp.1933~1935 (2001)
- American Diabetes Association, "Consensus development conference on the diagnosis of coronary heart disease in people with diabetes", Diabetes Care, 21, pp.1551~1559 (1998)
- Barthelemy O, "Silent myocardial ischemia screening in patients with diabetes mellitus", Arq Bras Endocrinol Metabol, 51, pp.285~293 (2007)
- Torremocha F, "Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective followup study of primary prevention in 72 diabetic patients", Diabetes Metab, 27, pp.49~57 (2001)
- Cesari M, "Inflammatory markers and onset of cardiovascular events: results from the Health ABC Study", Circulation, 108, pp.2317~2322 (2003)